
Pomalyst monopoly case: Bristol Myers wins dismissal of lawsuit
Ramos said the plaintiff purchasers failed to establish fraud in the procurement of six patents related to Pomalyst. As per Reuters, he also said they failed to show how nine lawsuits that Celgene filed between 2017 and 2020 against generic drug producers …